Thomas Tawadros

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


36 publications

2024 | 2023 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2009 | 2008 | 2007 | 2005 | 2003 | 2002 | 2001 |
2024
The role of preoperative immunonutrition on morbidity and immune response after cystectomy: protocol of a multicenter randomized controlled trial (INCyst Trial).
Derré L., Crettenand F., Grilo N., Stritt K., Kiss B., Tawadros T., Domingos-Pereira S., Roth B., Cerantola Y., Lucca I., 2024/10/17. Trials, 25 (1) p. 687. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2F7915DE0ADE]
Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study.
Cloître M., Benkhaled S., Boughdad S., Schaefer N., Prior J.O., Zeverino M., Berthold D., Tawadros T., Meuwly J.Y., Martel P. et al., 2024/05/31. Cancers, 16 (11). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F69D11E34A2A]
2023
Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study.
Cloitre M., Valerio M., Mampuya A., Rakauskas A., Berthold D., Tawadros T., Meuwly J.Y., Heym L., Duclos F., Vallet V. et al., 2023/04/01. The British journal of radiology, 96 (1145) p. 20220803. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB3AC2C2AFDE]
2021
Infirmière clinicienne de centre du cancer : l’expérience du Centre de la prostate du CHUV [Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]
Codeluppi C., Ninane F., Jolliet L., Glemarec P., Orcurto A., Rakauskas A., Tawadros T., Bosshard P., Eicher M., Herrera F. et al., 2021/12/01. Revue medicale suisse, 17 (761) pp. 2082-2085. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B3EF72B4777A]
Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study.
Rakauskas A., Tawadros T., Lucca I., Herrera F., Bourhis J., Burruni R., Gomes M.N., Codeluppi C., Jolliet L., La Rosa S. et al., 2021/07. Investigative and clinical urology, 62 (4) pp. 416-422. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_11DA8B398364]
2019
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8<sup>+</sup> T cells.
Mastelic-Gavillet B., Navarro Rodrigo B., Décombaz L., Wang H., Ercolano G., Ahmed R., Lozano L.E., Ianaro A., Derré L., Valerio M. et al., 2019/10/10. Journal for immunotherapy of cancer, 7 (1) p. 257. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC3C085DEA43]
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
Herrera F.G., Valerio M., Berthold D., Tawadros T., Meuwly J.Y., Vallet V., Baumgartner P., Thierry A.C., De Bari B., Jichlinski P. et al., 2019/02/01. International journal of radiation oncology, biology, physics, 103 (2) pp. 320-334. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8A5A6B3310C5]
Double Positive CD4<sup>+</sup>CD8<sup>+</sup> T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization.
Bohner P., Chevalier M.F., Cesson V., Rodrigues-Dias S.C., Dartiguenave F., Burruni R., Tawadros T., Valerio M., Lucca I., Nardelli-Haefliger D. et al., 2019. Frontiers in immunology, 10 p. 622. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4BC4F69D1158]
2017
 
Establishing a formal sarcoma center for children and adults at the Lausanne University Hospital
Bosisio Francesca, Matter Maurice, Fortin Aurélie, CHUV Multidisciplinary Sarcoma Team, 2017. Swiss Knife 3 pp. 16-19. Peer-reviewed.
[serval:BIB_B13928EA1DBE]
2016
 
Addressing overtreatment following the diagnosis of localized prostate cancer.
Tawadros T., Valerio M., 2016. Expert Review of Anticancer Therapy, 16 (4) pp. 373-374. Peer-reviewed.
[DOI][Pmid][serval:BIB_F63BFDE5E128]
 
The role of renal biopsy in small renal masses.
Burruni R., Lhermitte B., Cerantola Y., Tawadros T., Meuwly J.Y., Berthold D., Jichlinski P., Valerio M., 2016. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 10 (1-2) pp. E28-33. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E17D73E719CC]
2015
 
Biopsies de la prostate en 2015: quelle biopsie pour quel patient [Prostate biopsy: which strategy for which patient?].
Burruni R., Cerantola Y., Meuwly J.Y., Tawadros T., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (497) pp. 2288-90, 2292.
[Pmid][serval:BIB_84B39813FF24]
 
External urethral sphincter electromyography in asymptomatic women and the influence of the menstrual cycle.
Tawadros C., Burnett K., Derbyshire L.F., Tawadros T., Clarke N.W., Betts C.D., 2015. Bju International, 116 (3) pp. 423-431. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_447BC24476CC]
2014
 
Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer.
Brown M., Roulson J.A., Hart C.A., Tawadros T., Clarke N.W., 2014. British Journal of Cancer, 110 (8) pp. 2099-2108.
[DOI][WoS][Pmid][serval:BIB_B0B7DCCD612B]
 
Fungus ball in the urinary tract: A rare entity.
Praz V., Burruni R., Meid F., Wisard M., Jichlinski P., Tawadros T., 2014. Canadian Urological Association Journal = Journal de l'Association des Urologues du Canada, 8 (1-2) pp. E118-E120.
[DOI][Pmid][serval:BIB_FE30C5EF00B9]
 
Thérapie focale du cancer de la prostate: rationnel, résultats et perspectives [Focal therapy in prostate cancer: rationale, results and perspectives].
Valerio M., Benamran D., Tawadros T., Cerantola Y., Meuwly J.Y., Lutchmaya-Flick C., Lhermitte B., Wirth G., Iselin C., Jichlinski P., 2014. Revue Médicale Suisse, 10 (453) pp. 2306-2310. Peer-reviewed.
[Pmid][serval:BIB_E22C4882AE84]
2013
 
Centre de la prostate: une approche multidisciplinaire pour une prise en charge globale du patient [Prostate cancer center: a multidisciplinary approach to accurately manage patients with prostate cancer]
Tawadros T., Burruni R., Herrera F., Codeluppi C., Zurkinden C., Meuwly J.Y., Lhermitte B., Berthold D., 2013. Revue Médicale Suisse, 9 (409) pp. 2270-2, 2274.
[Pmid][serval:BIB_AA917B8978EC]
 
Immunothérapie: une nouvelle arme contre le cancer de la prostate [Immunotherapy: a therapeutic revolution against prostate cancer?].
Pracht M., Herrera F.G, Tawadros T., Berthold D., 2013. Revue Médicale Suisse, 9 (387) pp. 1070-1075. Peer-reviewed.
[Pmid][serval:BIB_872CCC33F242]
Intérêt d'une Consultation spécialisée multidisciplinaire en neuro-urologie et urologie fonctionnelle [Benefit of a specialized multidisciplinary clinic in neuro-urology and functional urology].
Tawadros C., Tawadros T., Julita L., Jichlinski P., Schurch B., 2013. Revue Médicale Suisse, 9 (409) pp. 2286-2288. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_304EA992D812]
 
Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T., Alonso F., Jichlinski P., Clarke N., Calandra T., Haefliger J.A., Roger T., 2013. Endocrine-Related Cancer, 20 (1) pp. 137-149.
[DOI][WoS][Pmid][serval:BIB_4EBA811E0FF4]
2012
 
The differential effects of statins on the metastatic behaviour of prostate cancer.
Brown M., Hart C., Tawadros T., Ramani V., Sangar V., Lau M., Clarke N., 2012/05/08. British journal of cancer, 106 (10) pp. 1689-1696. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C3C39FAA96FF]
 
Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.
Tawadros T., Brown M.D., Hart C.A., Clarke N.W., 2012. British Journal of Cancer, 107 (10) pp. 1737-1744.
[DOI][WoS][Pmid][serval:BIB_1E93527F8E1A]
2009
Dépistage du cancer de la prostate: actualité [Prostate cancer screening: an update]
Tawadros T., Doerfler A., Treuthardt C., Praz V., Levi F., Zouhair A., Berthold D., Bauer J., Iselin C., Jichlinski P., 2009/12/02. Revue medicale suisse, 5 (228) pp. 2438-2441. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_11E9631D48D2]
La surveillance active dans la prise en charge du cancer de la prostate précoce [Active surveillance for early-stage prostate cancer]
Jichlinski P., Berthold D.R., Zouhair A., Griesser A.C., Meuwly J.Y., Prior J.O., Lhermitte B., Doerfler A., Treuthardt C., Praz V. et al., 2009/12/02. Revue medicale suisse, 5 (228) pp. 2442-2444,2446-2447. Peer-reviewed.
[DOI][Pmid][serval:BIB_66220A2D6BE9]
 
Ischemic cecal perforation secondary to ESWL of junctional stone in ureterosigmoidostomy (Mainz Pouch II).
Cardinaux C., Tawadros T., Praz V., Wisard M., Treuthardt C., Jichlinski P., 2009. Urology, 73 (6) pp. 1423.e1-2.
[DOI][WoS][Pmid][serval:BIB_62433A2CF1E2]
2008
 
Increased MIF secretion by neuroendocrine differentiated LNCAP cells induces proliferation and survival of prostate cancer cells
Tawadros T, Roger T, Calandra T, Haefliger J.A, Jichlinski P., 2008. dans Abstract Milan Congress.
[serval:BIB_6FBF784400E5]
Urologie [Trends in urology]
Uffer M., Chollet Y., Cardinaux C., Erling C., Praz V., Ramadani D., Tawadros T., Treutherdt C., Wisard M., Zarkik Y. et al., 2008. Revue médicale suisse, 4 (140) pp. 166-8. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1CFE1C128485]
2007
 
Splice variant-specific stabilization of JNKs by IB1/JIP1.
Yang J.Y., Moulin N., van Bemmelen M.X., Dubuis G., Tawadros T., Haefliger J.A., Waeber G., Widmann C., 2007. Cellular signalling, 19 (10) pp. 2201-7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_34A390AC6694]
 
Urologie. [Urology]
Chollet Y., Aymon D., Cardinaux C., Praz V., Tawadros T., Treuthardt C., Vaucher L., Wisard M., Zaman K., Zarkik Y. et al., 2007/01. Revue Médicale Suisse, 3 (94) pp. 168-71.
[Pmid][serval:BIB_CB4E40E526E1]
2005
 
IB1/JIP-1 controls JNK activation and increased during prostatic LNCaP cells neuroendocrine differentiation.
Tawadros T., Martin D., Abderrahmani A., Leisinger H.J., Waeber G., Haefliger J.A., 2005. Cellular Signalling, 17 (8) pp. 929-939. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_026BC83682AC]
2003
 
Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines.
Martin D., Tawadros T., Meylan L., Abderrahmani A., Condorelli D.F., Waeber G., Haefliger J.A., 2003. Journal of Biological Chemistry, 278 (52) pp. 53082-53089. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_442249D1FBA3]
 
The scaffold protein IB1/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic beta cells.
Haefliger J.A., Tawadros T., Meylan L., Gurun S.L., Roehrich M.E., Martin D., Thorens B., Waeber G., 2003. Journal of Cell Science, 116 (Pt 8) pp. 1463-1469.
[DOI][WoS][Pmid][serval:BIB_42B18BB6B855]
2002
 
Connexins 43 and 26 are differentially increased after rat bladder outlet obstruction.
Haefliger J.A., Tissières P., Tawadros T., Formenton A., Bény J.L., Nicod P., Frey P., Meda P., 2002. Experimental cell research, 274 (2) pp. 216-25. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7A5F3AEC658B]
 
The scaffold protein IB1/JIP-1 controls the activation of JNK in rat stressed urothelium.
Tawadros T., Formenton A., Dudler J., Thompson N., Nicod P., Leisinger H.J., Waeber G., Haefliger J.A., 2002. Journal of cell science, 115 (Pt 2) pp. 385-93. Peer-reviewed.
[WoS][Pmid][serval:BIB_5E7E586F7BC8]
2001
 
Connexin26 is regulated in rat urothelium by the scaffold protein IB1/JIP-1.
Tawadros T., Meda P., Leisinger H.J., Waeber G., Haefliger J.A., 2001. Cell communication & adhesion, 8 (4-6) pp. 303-6. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_801059A2D1A8]
 
Islet-brain1/JNK-interacting protein-1 is required for early embryogenesis in mice.
Thompson N.A., Haefliger J.A., Senn A., Tawadros T., Magara F., Ledermann B., Nicod P., Waeber G., 2001. Journal of Biological Chemistry, 276 (30) pp. 27745-27748. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B36FBEDF775C]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University